{"disease":{"id":"recurrent-and-refractory-solid-tumors","name":"recurrent and refractory solid tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03245151","title":"Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Eisai Inc.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}